Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirecta Plus Regulatory News (DCTA)

  • This share is currently suspended. It was suspended at a price of 6.75
  • There is currently no data for DCTA

Acquisition and Directa Textile Solutions launch

14 Nov 2016 07:00

RNS Number : 0365P
Directa Plus PLC
14 November 2016
 

14 November 2016

 

Directa Plus plc

("Directa Plus" or the "Company")

 

Acquisition of Osmotek and launch of Directa Textile Solutions

First implementation of the Company's downstream integration strategy

 

Directa Plus (AIM: DCTA), a producer and supplier of graphene-based products for use in consumer and industrial markets, is pleased to announce that its wholly-owned subsidiary, Directa Plus S.p.A., has acquired a 60% interest in the issued share capital of Osmotek Srl ("Osmotek"), a company involved in the commercialisation and distribution of textile membranes, for a total consideration of €60,000 to be invested in the business as working capital (the "Acquisition"). The Company has assumed responsibility for the operations of Osmotek, which has been renamed Directa Textile Solutions Srl ("DTS"). The Directors of the Company believe that the Acquisition will enhance the route-to-market for its textile applications.

 

Background to the Transaction

 

Osmotek, based in Milan, Italy, was founded in 2015, to focus on the commercialisation of textile membranes. Osmotek's focus in the textile membrane market is on sportswear, workwear, fashion and military applications. It has already built a base of clients and agents and has a good commercial pipeline.

 

Osmotek was founded by Novaresin, a large Italian membrane producer, and the existing shareholders of Osmotek will continue to hold a 40% shareholding in DTS post-Acquisition. Novaresin has a factory located in the North of Italy that is capable of producing 7 million metres of fabric per annum. It has a wide range of textile products and is a specialist in lamination whereby a textile membrane is laminated onto another fabric to enhance its properties, such as providing breathability or waterproofing. The Novaresin products include a new range of graphene-enhanced membranes for textile applications, which have been developed in conjunction with Directa Plus over the last year. The incorporation of the Company's graphene-based products enhances the textile membrane providing additional properties to the end fabric, such as electrical and thermal conductivity, bacteriostatic characteristics and abrasion resistance.

 

Rationale for the Transaction

 

The Acquisition and launch of DTS reflects the Company's strategy to utilise its know-how and IP to have a greater role in the graphene value chain. The main reasons for the Acquisition include:

 

· Directa Plus, through DTS, will directly promote and distribute its graphene-enhanced membrane products to textile brands and end clients.

· It will allow the Company to take advantage of the development to date of G+ membranes undertaken by Directa Plus and Novaresin, giving the Company greater control of the value and margin in the process from its development through to commercial sales.

· Directa Plus will be better positioned to communicate directly with the end client and pursue its branding strategy of featuring the 'G+' logo on the end product and packaging.

· DTS will leverage the integration of Directa Plus' technical capabilities regarding graphene, Novaresin's expertise in creating and producing technical membranes, and Osmotek's commercial structure, network and client portfolio.

· It advances the Company's stated strategy of targeting the smart textiles market.

 

Terms of the Acquisition

 

Directa Plus S.p.A has acquired a 60% interest in Osmotek for €60,000. The proceeds will be used for ongoing working capital purposes. The existing shareholders of Osmotek have not sold any shares in the transaction and remain committed to the business.

 

Osmotek was incorporated in September 2015 and, based on unaudited management information, in the period from incorporation to 31 October 2016 revenues were approximately €150,000 and it has reached its target of operating profit breakeven.

 

Under the terms of the Acquisition, Directa Plus S.p.A. will be the sole supplier of graphene-based products to Novaresin which will then produce the graphene-enhanced membranes that will be commercialised through DTS. Novaresin will provide the graphene-enhanced membranes exclusively to DTS and is prohibited from selling them directly to third parties.

 

Directa Plus will be responsible for the DTS operations, which will be based at the Company's existing headquarters in Lomazzo, Italy.

 

Giulio Cesareo, Chief Executive Officer of Directa Plus, said: "The establishment of Directa Textile Solutions represents a key milestone of our downstream integration strategy, and another step in the execution of our business plan. By moving up the value chain, we will be able to generate revenues from the provision of our G+ and also from the sale of the graphene-enhanced membrane to the end customer. Equally, we will be better able to communicate directly with major brands and so provide a product that meets their exact needs as well as pursuing our ingredient branding strategy.

 

"The market for smart textiles is vast. By partnering with a leading producer of textile membranes, Novaresin, with whom we have been working closely over the last year to develop graphene-enhanced textile membranes that are already being tested by a range of potential customers, we are strengthening our ability to target this key segment with our innovative, tailor-made solutions that have been independently certified as safe for human health and the environment. As a result, we are very excited about the prospects for Directa Plus Textile Solutions, which further increases our competitive position in the industry."

 

This announcement contains inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations

 

Enquiries

 

Directa Plus plc

 

Giulio Cesareo, CEO

Marco Ferrari, CFO

+39 02 36714458

 

 

Cantor Fitzgerald Europe (Nominated Adviser and Broker)

 

Marc Milmo, David Foreman, Michael Reynolds (Corporate Finance)

Mark Westcott, David Banks (Sales)

+44 20 7894 7000

 

 

Luther Pendragon (Financial PR)

 

Harry Chathli, Claire Norbury, Alexis Gore

+44 20 7618 9100

 

About Directa Plus

 

Directa Plus is one of the largest producers and suppliers of graphene-based products for use in consumer and industrial markets worldwide. By incorporating Directa Plus' unique graphene blends, identified by the G+ brand, its customers can enhance the performance of their end products without significantly increasing their cost. Directa Plus graphene-based products are natural, chemical-free, sustainably produced and tailored to specific customer requirements for commercial applications such as smart textiles, tyres, composite materials and environmental solutions.

 

Established in 2005, the Company has a patented technology process and a scalable and exportable manufacturing model. It produces graphene-based products at its own factory in Lomazzo, Italy, and can set up additional production at customer locations to reduce transport costs, waste and time-to-utilisation. Directa Plus partners with customers to enable them to offer the high-performance benefits of graphene in their own products.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLFFIILVLVLIR
Date   Source Headline
28th May 20267:00 amRNSCancellation - Directa Plus plc
27th Apr 20266:00 pmRNSDirecta Plus
27th Apr 20263:21 pmRNSAppointment of Administrators
14th Apr 20267:00 amRNSUpdate on Funding
13th Apr 20267:43 amRNSUpdate on Further Funding
13th Apr 20267:42 amRNSSuspension - Directa Plus PLC
30th Mar 20267:00 amRNSUpdate on Funding
20th Mar 20267:00 amRNSAIM Rule 17 and Schedule 2(g) update
27th Feb 20267:00 amRNSUpdate on Funding and Board change
7th Jan 20267:00 amRNSFull year trading and operational update
15th Dec 20253:26 pmRNSGrant of 2025 LTIP Awards
24th Sep 20257:00 amRNSHalf Year Report
17th Sep 20257:00 amRNSNotice of interim results presentations
4th Aug 202511:26 amRNSPDMR Dealing
4th Aug 20257:00 amRNSHalf Year Trading Update and Notice of Results
30th Jun 20255:03 pmRNSResult of AGM
19th Jun 20257:00 amRNSDirector/PDMR Shareholding
17th Jun 20257:00 amRNSDirector/PDMR Shareholding
16th Jun 20253:27 pmRNSDirector/PDMR Shareholding
16th Jun 202511:34 amRNSDirector/PDMR Shareholding
10th Jun 20257:00 amRNSNotice of Investor Presentation
6th Jun 20257:00 amRNSPosting of Annual Report and Notice of AGM
3rd Jun 20257:00 amRNSFinal Results
28th May 20257:00 amRNSNotice of Results
14th Apr 20257:00 amRNSContract Win
7th Apr 20257:00 amRNSTrading and Operational Update & Notice of Results
10th Feb 20257:00 amRNSSetcar secures a new contract win and a renewal
19th Nov 20247:00 amRNSAppointment of Nominated Adviser and Broker
25th Sep 20247:00 amRNSHalf-year Report
13th Sep 20247:00 amRNSNotice of Results
26th Jul 20244:33 pmRNSResult of General Meeting
4th Jul 20242:24 pmRNSNotification of major holdings
2nd Jul 20244:23 pmRNSNotification of major holdings
1st Jul 20243:16 pmRNSNotification of major holdings
28th Jun 20243:09 pmRNSDirectors’ Participation in Fundraising
28th Jun 20242:57 pmRNSHolding(s) in Company
28th Jun 202412:09 pmRNSPosting of Annual Report & Accounts
27th Jun 20243:50 pmRNSResult of AGM & GM
26th Jun 20247:00 amRNSFinal Results
24th Jun 20247:00 amRNSUpdate on Voting & Action to be Taken
12th Jun 20241:06 pmRNSPosting of Circular and Notice of General Meeting
11th Jun 202410:40 amRNSResult of Placing and Subscription
11th Jun 20247:00 amRNSProposed equity raise
3rd Jun 20247:00 amRNSNotice of AGM
29th May 20247:00 amRNSGipave selected for Rome 2025 Jubilee project
15th Apr 20243:01 pmRNSNotification of major holdings
12th Apr 20247:00 amRNSGiPave® installed at Imola Circuit
25th Mar 20247:00 amRNSEUR 1,000,000 Loan Agreement Signed
22nd Mar 20247:00 amRNSCollaboration with UK-based Heathcoat Fabrics
26th Feb 20247:00 amRNSAcquisition of 49% minority interest in Setcar

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.